Filing Details

Accession Number:
0001396677-13-000033
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-15 15:15:06
Reporting Period:
2013-05-13
Filing Date:
2013-05-15
Accepted Time:
2013-05-15 15:15:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1050007 Nutraceutical International Corp NUTR Medicinal Chemicals & Botanical Products (2833) 870515089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265855 E Stanley Soper C/O Nutraceutical International Corp
1400 Kearns Blvd 2Nd Fl.
Park City UT 84060
Vp, Legal Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-13 2,500 $12.32 2,500 No 4 M Direct
Common Stock Disposition 2013-05-13 2,500 $18.47 0 No 4 S Direct
Common Stock Acquisiton 2013-05-14 7,168 $12.32 7,168 No 4 M Direct
Common Stock Disposition 2013-05-14 7,168 $18.69 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-05-13 2,500 $0.00 2,500 $12.32
Common Stock Employee Stock Option (right to buy) Disposition 2013-05-14 7,168 $0.00 7,168 $12.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,668 2013-12-17 No 4 M Direct
2,500 2013-12-17 No 4 M Direct
Footnotes
  1. Exercise of options expiring on December 17, 2013.
  2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 29, 2013.
  3. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $18.37 to $18.50. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $18.67 to $18.75. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. The option vested in six equal installments every six months beginning on June 17, 2004.